Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
Alain Amstutz(University Hospital of Basel), Matthias Briel(University of Basel), Tyler Bonnett(National Institutes of Health), Charles Burdet(Université Paris Cité), Fredrik Müller(Oslo University Hospital), Mike Fralick(University of Toronto), Fridtjof Lund‐Johansen(Oslo University Hospital), Lori E. Dodd(National Institutes of Health), Perrine Janiaud(University Hospital of Basel), Benjamin Speich(University Hospital of Basel), France Mentré(Inserm), Corina S. Rueegg(Oslo University Hospital), Soheila Aghlmandi(University Hospital of Basel), Mary‐Anne Trabaud(Hospices Civils de Lyon), Ala Taji Heravi(University Hospital of Basel), Dominique Costagliola(Inserm), Kari A.O. Tikkinen(University of Helsinki), Alexandra Griessbach(University Hospital of Basel), Drifa Belhadi(Inserm), Todd C. Lee(McGill University Health Centre), Maya Hites(Université Libre de Bruxelles), Florence Ader(Université Claude Bernard Lyon 1), Srinivas Murthy, Olli Nevalainen(Hatanpää Hospital), Yazdan Yazdanpanah, Inge Christoffer Olsen(Oslo University Hospital), Laura Werlen(University Hospital of Basel), Stefan Schandelmaier(University Hospital of Basel), Andreas Barratt‐Due(Oslo University Hospital), Lambert Assoumou(Inserm), Bin Cao(Shandong Provincial Hospital), Yeming Wang(Academy of Medical Sciences), Maude Bouscambert(Hospices Civils de Lyon), Christof Schönenberger(University Hospital of Basel), Ruxandra Pinto(Sunnybrook Health Science Centre)
Cited by 124
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k